Life Sciences

A leading pharma company was concerned about the impact of biosimilars in its key therapeutic categories. CRA coordinated the development and implementation of risk mitigation strategies across the client’s teams and that were subsequently integrated into brand plans.
A global pharma company abandoned a product launch following unfavorable clinical trial results. When their stock price fell, they were sued for allegedly concealing product information. The court accepted CRA’s analysis and conclusion that the alleged information concealment was an unlikely reason for the price change.
A global pharma company sought insight into the policy implications of variations in access to Multiple Sclerosis treatments across Europe. CRA’s analysis and report has helped the company build its argumentation to policy makers around barriers to effective MS treatment.

CRA’s Life Sciences practice helps pharmaceutical, biotechnology, diagnostics and medical device companies achieve optimum performance across key aspects of their business, including innovation, commercial success, organization, and reputation, all for the long-term benefit of patients, clinicians, employees, and shareholders. We work with life sciences businesses directly as well as with their legal counsel, industry associations, government organizations, and advocacy groups from the earliest stages of research into new therapy areas, through product development, to the delivery of products that will achieve commercial success and fulfill the expectations of our clients and their key stakeholders.
Learn more

How else can we support you?

Take a look at our competitive benefits.

Healthcare from day one	Tuition assistance	Immigration support
401k plan with matching contributions	Office social events & volunteer opportunities	Employee discounts
Parental leave	Wellness program	Stand-up desks
Free snacks & beverages	Paid time off	Pet insurance